Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 02-2012 | 11-2011 | 08-2011 | 05-2011 | 02-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 494 | 313 | 118 | 157 | 61 |
| Depreciation Amortization | 130 | 87 | 43 | 148 | 110 |
| Accounts receivable | -633 | -418 | -140 | 262 | 34 |
| Other Working Capital | -591 | -370 | -77 | 46 | -124 |
| Other Operating Activity | 703 | 465 | 164 | -284 | -15 |
| Operating Cash Flow | $103 | $76 | $108 | $329 | $66 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -136 | -49 | -40 | -141 | -84 |
| Purchase Of Investment | N/A | N/A | N/A | -165 | N/A |
| Purchase Sale Intangibles | -50 | -25 | -25 | -125 | -99 |
| Other Investing Activity | -50 | -25 | -25 | -125 | -99 |
| Investing Cash Flow | $-186 | $-74 | $-65 | $-432 | $-183 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -35 | -24 | -12 | -45 | -34 |
| Common Stock Issued | 29 | 0 | N/A | 83 | N/A |
| Financing Cash Flow | $-7 | $-24 | $-12 | $38 | $-34 |
| Exchange Rate Effect | -2 | -2 | 0 | -1 | -1 |
| Beginning Cash Position | 989 | 989 | 989 | 1,055 | 1,055 |
| End Cash Position | 899 | 966 | 1,021 | 989 | 904 |
| Net Cash Flow | $-91 | $-23 | $31 | $-66 | $-151 |
| Free Cash Flow | |||||
| Operating Cash Flow | 103 | 76 | 108 | 329 | 66 |
| Capital Expenditure | -136 | -49 | -40 | -141 | -84 |
| Free Cash Flow | -32 | 27 | 69 | 188 | -18 |